Targeting Nrf2 signaling pathway: new therapeutic strategy for cardiovascular diseases

被引：0

作者：

Wu, Qi ^{[1
]}

Yao, Jiangting ^{[1
]}

Xiao, Mengyun ^{[1
]}

Zhang, Xiawei ^{[1
]}

Zhang, Mengxiao ^{[2
]}

Xi, Xinting ^{[1
]}

机构：

[1] Bengbu Med Univ, Sch Med Imaging, Bengbu, Peoples R China

[2] Bengbu Med Univ, Sch Pharm, Bengbu, Peoples R China

来源：

JOURNAL OF DRUG TARGETING | 2024年 / 32卷 / 08期

基金：

中国国家自然科学基金;

关键词：

Nuclear factor erythroid 2-related factor 2 (Nrf2); cardiovascular diseases (CVDs); oxidative stress (OS); therapeutic strategy; Nrf2; activators; OXIDATIVE STRESS; ENDOTHELIAL DYSFUNCTION; HEART-FAILURE; HYPERTENSION; MICE; PATHOPHYSIOLOGY; SUPPRESSES; ACTIVATION; EXPRESSION; APOPTOSIS;

D O I：

10.1080/1061186X.2024.2356736

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Cardiovascular diseases (CVDs) are the leading cause of death globally, with oxidative stress (OS) identified as a primary contributor to their onset and progression. Given the elevated incidence and mortality rates associated with CVDs, there is an imperative need to investigate novel therapeutic strategies. Nuclear factor erythroid 2-related factor 2 (Nrf2), ubiquitously expressed in the cardiovascular system, has emerged as a promising therapeutic target for CVDs due to its role in regulating OS and inflammation. This review aims to delve into the mechanisms and actions of the Nrf2 pathway, highlighting its potential in mitigating the pathogenesis of CVDs.

引用

页码：874 / 883

页数：10

共 116 条

[1] Nrf2 and Heme Oxygenase-1 Involvement in Atherosclerosis Related Oxidative Stress [J].

Alonso-Pineiro, Jose Angel ;

Gonzalez-Rovira, Almudena ;

Sanchez-Gomar, Ismael ;

Moreno, Juan Antonio ;

Duran-Ruiz, Ma Carmen .

ANTIOXIDANTS, 2021, 10 (09)

[2] HEME OXYGENASES IN CARDIOVASCULAR HEALTH AND DISEASE [J].

Ayer, Anita ;

Zarjou, Abolfazl ;

Agarwal, Anupam ;

Stocker, Roland .

PHYSIOLOGICAL REVIEWS, 2016, 96 (04) :1449-1508

[3] Cardio protective role of wogonin loaded nanoparticle against isoproterenol induced myocardial infarction by moderating oxidative stress and inflammation [J].

Bei, Wan ;

Jing, Li ;

Chen, Nie .

COLLOIDS AND SURFACES B-BIOINTERFACES, 2020, 185

[4] The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis [J].

Bersuker, Kirill ;

Hendricks, Joseph M. ;

Li, Zhipeng ;

Magtanong, Leslie ;

Ford, Breanna ;

Tang, Peter H. ;

Roberts, Melissa A. ;

Tong, Bingqi ;

Maimone, Thomas J. ;

Zoncu, Roberto ;

Bassik, Michael C. ;

Nomura, Daniel K. ;

Dixon, Scott J. ;

Olzmann, James A. .

NATURE, 2019, 575 (7784) :688-+

[5] Resveratrol and Cardiovascular Diseases [J].

Bonnefont-Rousselot, Dominique .

NUTRIENTS, 2016, 8 (05)

[6] Structural basis of Keap1 interactions with Nrf2 [J].

Canning, Peter ;

Sorrell, Fiona J. ;

Bullock, Alex N. .

FREE RADICAL BIOLOGY AND MEDICINE, 2015, 88 :101-107

[7] Tanshinone IIA attenuates neuropathic pain via inhibiting glial activation and immune response [J].

Cao, Fa-Le ;

Xu, Min ;

Wang, Yan ;

Gong, Ke-Rui ;

Zhang, Jin-Tao .

PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2015, 128 :1-7

[8] The crosstalk between Nrf2 and NF-?B pathways in coronary artery disease: Can it be regulated by SIRT6? [J].

Casper, Eman .

LIFE SCIENCES, 2023, 330

[9] Klotho Deficiency Causes Heart Aging via Impairing the Nrf2-GR Pathway [J].

Chen, Kai ;

Wang, Shirley ;

Sun, Qiwei Wilton ;

Zhang, Bo ;

Ullah, Mujib ;

Sun, Zhongjie .

CIRCULATION RESEARCH, 2021, 128 (04) :492-507

[10] Nrf2 at the heart of oxidative stress and cardiac protection [J].

Chen, Qin M. ;

Maltagliati, Anthony J. .

PHYSIOLOGICAL GENOMICS, 2018, 50 (02) :77-97

← 1 2 3 4 5 6 7 8 9 10 →